Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
50 participants
INTERVENTIONAL
2015-07-31
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The doses that will be used in the study were within usual dose limits which is stated in prospectus of the study drug.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Efficacy of Different Bupivacaine Concentrations in Pediatric Patients Undergoing Transversus Abdominis Plane Block
NCT04202367
Analgesic Comparison of Transversus Fascial Plane and Quadratus Lumborum Blocks in Pediatric Urogenital Procedures
NCT07256899
Caudal Epidural Vs. TAP Block for Postoperative Analgesia in Pediatric Infraumbilical Surgery: a RCT
NCT06895382
Erector Spinae Plane Block for Peri-operative Pain Management in Pediatric Open Pyeloplasty Cases
NCT03790566
Transversus Abdominis Plane Block and Quadratus Lumborum Block in Pediatric Patients
NCT04209478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Levobupivacaine high volume
TAP block with levobupivacaine 0.25% of 0.5 ml/kg under general anesthesia
Levobupivacaine
Transversus abdominis plane block with levobupivacaine
Group Levobupivacaine low volume
TAP block with levobupivacaine 0.25% of 0.25 ml/kg under general anesthesia
Levobupivacaine
Transversus abdominis plane block with levobupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levobupivacaine
Transversus abdominis plane block with levobupivacaine
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged between 2 and 12
Exclusion Criteria
* Patients with chronic pain
* Patients having infection at the site of intervention
* Patients with a history of allergy
* Patients having chronic diseases (hepatic dysfunction, renal failure)
2 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emel Uyar
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neslihan Alkis
Role: STUDY_DIRECTOR
Ankara University Medical Faculty
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
931893045140401
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.